Oral Answers to Questions

Debate between George Freeman and Andrew Stephenson

Tuesday 10th May 2016 Commons Chamber

[George Freeman]

My hon. Friend makes a really interesting point. It goes to the heart of the work that we are doing at the moment with CCGs, in terms of use of data to map and track prescribing practice across the system. I will happily pick up the point about ensuring that biosimilars are incorporated in that.

[Andrew Stephenson (Pendle) (Con)]

4. What progress has been made on improving diagnosis and treatment of Lyme disease.